[HTML][HTML] Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations

T Mitsudomi - Translational lung cancer research, 2014 - ncbi.nlm.nih.gov
Lung cancer is a leading cause of cancer-related mortality in many countries. Although
recent advances in targeted therapy against driver oncogenes have significantly improved …

Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations

T Mitsudomi - Translational lung cancer research, 2014 - pubmed.ncbi.nlm.nih.gov
Lung cancer is a leading cause of cancer-related mortality in many countries. Although
recent advances in targeted therapy against driver oncogenes have significantly improved …

[PDF][PDF] Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations

T Mitsudomi - Korea - cdn.amegroups.cn
Lung cancer is a leading cause of cancer-related mortality in many countries. Although
recent advances in targeted therapy against driver oncogenes have significantly improved …

Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations.

T Mitsudomi - Translational Lung Cancer Research, 2014 - europepmc.org
Lung cancer is a leading cause of cancer-related mortality in many countries. Although
recent advances in targeted therapy against driver oncogenes have significantly improved …

Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations

T Mitsudomi - Translational Lung Cancer Research, 2014 - tlcr.amegroups.org
Lung cancer is a leading cause of cancer-related mortality in many countries. Although
recent advances in targeted therapy against driver oncogenes have significantly improved …

[HTML][HTML] Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations

T Mitsudomi - Translational Lung Cancer Research, 2014 - tlcr.amegroups.org
Lung cancer is a leading cause of cancer-related mortality in many countries. Although
recent advances in targeted therapy against driver oncogenes have significantly improved …